TI
Tropogenix, Inc.
SEC filingBiotechnology · San Antonio, TX
Amount raised$250Ksold at filing
Total offering$2.5M$2.3M still open
Investors in the raise1count reported to the SEC
FiledSep 30, 2025first sale Sep 26, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Paul CastellaExecutive Officer, Director
Kristen ParkerDirector
Kevin MeehanDirector
Bryan DanielsDirector
Executive officers, directors and promoters as listed on the Form D.